发明名称 TRI-HETEROCYCLIC COMPOUNDS AND A PHARMACEUTICAL COMPRISING THEM AS AN ACTIVE INGREDIENT
摘要 Tri-heterocyclic compound of formula (I) (see formula I) wherein each of W, X and Y is carbon or nitrogen; each of U and Z is CR2, NR13, nitrogen, oxygen, sulfur etc.: A ring is carbocyclic ring, heterocyclic ring; R1 is alkyl, alkenyl, alkynyl, NR4R5, OR6 etc.: R3 is carbocyclic ring, heterocyclic ring: and a pharmaceutically acceptable salt thereof, a process for the preparation thereof, a pharmaceutical comprising them as an active ingredient. A compound of formula (I) is useful, in order to possess corticotropin releasing factor receptor antagonistic activity, for the prevention and/or treatment of depression, anxiety, eating disorder, postraumatic stress disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcohol dependence syndrome etc.
申请公布号 CA2432148(C) 申请公布日期 2011.01.18
申请号 CA20012432148 申请日期 2001.12.27
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 NAKAI, HISAO;KAGAMIISHI, YOSHIFUMI
分类号 C07D471/04;C07D487/04;A61K31/437;A61K31/519;A61P1/00;A61P1/04;A61P1/08;A61P1/10;A61P1/12;A61P1/14;A61P3/04;A61P3/08;A61P5/14;A61P9/00;A61P9/02;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/02;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P27/02;A61P29/00;A61P37/08;A61P43/00;C07D207/00;C07D231/00;C07D239/00;C07D307/00;C07D333/00;C07D487/14;C07D491/14;C07D491/147;C07D495/14 主分类号 C07D471/04
代理机构 代理人
主权项
地址